{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:01:13Z","timestamp":1760821273517},"reference-count":27,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"unspecified","delay-in-days":166,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>Characteristics and research collaboration of registered systematic reviews (SRs) on treatment modalities for coronavirus disease-2019 (COVID-19) remain unclear. This study analysed research collaboration, interventions and outcome measures in registered SRs on COVID-19 treatments and pointed out the relevant problems. PROSPERO (international prospective register of systematic reviews) was searched for SRs on COVID-19 treatments as of 2 June 2020. Excel 2016 was used for descriptive analyses of the extracted data. VOSviewer 1.6.14 software was used to generate network maps for collaborations between countries and institutions. A total of 189 SRs were included, which were registered by 301 institutions from 39 countries. China (69, 36.50%) exhibited the highest output. Cooperation between countries was not close enough. As an institution, the Chengdu University of Traditional Chinese Medicine (7, 3.70%) had the highest output. There was close cooperation between institutions. Interventions included antiviral therapy (81, 42.86%), respiratory support (16, 8.47%), circulatory support (11, 5.82%), plasma therapy for convalescent patients (11, 5.82%), immunotherapy (9, 4.76%), TCM (traditional Chinese medicine) treatment (9, 4.76%), rehabilitation treatment (5, 2.65%), anti-inflammatory treatment (16, 8.47%) and other treatments (31, 16.40%). Concerning antiviral therapy (81, 42.86%), the most commonly used antiviral agents were chloroquine\/hydroxychloroquine (26, 13.76%), followed by remdesivir (12, 6.35%), lobinavir\/ritonavir (11, 5.82%), favipiravir (5, 2.65%), ribavirin (5, 2.65%), interferon (5, 2.65%), abiron (4, 2.12%) and abidor (4, 2.12%). The most frequently used primary and secondary outcomes were the mortality rate (92, 48.68%) and hospital stay length (48, 25.40%), respectively. The expression of the outcomes was not standardised. Many COVID-19 SRs on treatment modalities have been registered, with a low completion rate. Although there was some collaboration between countries and institutions in the currently registered SRs on treatment modalities for COVID-19 on PROSPERO, cooperation between countries should be further enhanced. More attention should be directed towards identifying deficiencies of outcome measures, and the standardisation of results should be maximised.<\/jats:p>","DOI":"10.1017\/s0950268821001321","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T02:43:43Z","timestamp":1623811423000},"update-policy":"http:\/\/dx.doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":4,"title":["Characteristics of systematic reviews evaluating treatments for COVID-19 registered in PROSPERO"],"prefix":"10.1017","volume":"149","author":[{"given":"Ruinian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dairong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongna","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"S0950268821001321_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.07.002"},{"key":"S0950268821001321_ref5","unstructured":"5. Organization, W.H. Naming the coronavirus disease (COVID-19) and the virus that causes it. Available at https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it (Accessed 10 August 2020)."},{"key":"S0950268821001321_ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.570893"},{"key":"S0950268821001321_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105472"},{"key":"S0950268821001321_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.06.005"},{"key":"S0950268821001321_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2020.100644"},{"key":"S0950268821001321_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2020.100490"},{"key":"S0950268821001321_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"S0950268821001321_ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"S0950268821001321_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.05.022"},{"key":"S0950268821001321_ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01233-w"},{"key":"S0950268821001321_ref1","first-page":"m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ (Clinical Research Ed)"},{"key":"S0950268821001321_ref7","unstructured":"7. World Health Organization. Coronavirus disease (COVID-2019) situation reports. Available at https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports (Accessed 21 August 2020)."},{"key":"S0950268821001321_ref6","first-page":"e7357","article-title":"A bibliometric analysis of COVID-19 research activity: a call for increased output","volume":"12","author":"Chahrour","year":"2020","journal-title":"Cureus"},{"key":"S0950268821001321_ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-019-00552-z"},{"key":"S0950268821001321_ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240123"},{"key":"S0950268821001321_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.03.045"},{"key":"S0950268821001321_ref18","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0810"},{"key":"S0950268821001321_ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-019-05071-8"},{"key":"S0950268821001321_ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00477"},{"key":"S0950268821001321_ref22","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.6.2000110"},{"key":"S0950268821001321_ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.554247"},{"key":"S0950268821001321_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"S0950268821001321_ref17","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S132808"},{"key":"S0950268821001321_ref23","unstructured":"23. State Administration of Traditional Chinese Medicine and National Health Commission. Guideline of Diagnosis and Treatment of COVID-19 (7th ed.). Available at http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202003\/46c9294a7dfe4cef80dc7f5912eb1989.shtml (Accessed 1 August 2020)."},{"key":"S0950268821001321_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104896"},{"key":"S0950268821001321_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.12.004"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268821001321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T06:42:37Z","timestamp":1625035357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268821001321\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":27,"alternative-id":["S0950268821001321"],"URL":"https:\/\/doi.org\/10.1017\/s0950268821001321","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Copyright \u00a9 The Author(s), 2021. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e146"}}